Human Genome Sciences, U.S. Department of Health and Human Services sales and marketing update

Human Genome said the U.S. government exercised an option to purchase 45,000 more doses of ABthrax raxibacumab anthrax vaccine. The company expects to receive $151 million in revenue from the order as it completes deliveries over a three-year period beginning near year end. In April, Human Genome completed delivery of 20,000 doses of ABthrax to the U.S. Strategic National Stockpile. ...